Drug Bests Laser for Preemie Eye Disorder (CME/CE)
(MedPage Today) -- The use of bevacizumab (Avastin) for the treatment of retinopathy of prematurity appears better than conventional laser therapy -- and may be a significant advance in a disease that often leads to childhood blindness, results of a prospective study showed.